Fonte: Critical Care Medicine. Unidades: FORP, FMRP
Assuntos: METALOPROTEINASES, EMBOLIA PULMONAR, HIPERTENSÃO PULMONAR, TROMBOEMBOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NETO-NEVES, Evandro Manoel et al. Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism. Critical Care Medicine, v. 39, n. 2, p. 349-356, 2011Tradução . . Disponível em: https://doi.org/10.1097/ccm.0b013e3181fa3dfe. Acesso em: 11 nov. 2024.APA
Neto-Neves, E. M., Dias-Júnior, C. A., Rizzi, E., Castro, M. M. de, Sônego, F., Gerlach, R. F., & Santos, J. E. T. dos. (2011). Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism. Critical Care Medicine, 39( 2), 349-356. doi:10.1097/ccm.0b013e3181fa3dfeNLM
Neto-Neves EM, Dias-Júnior CA, Rizzi E, Castro MM de, Sônego F, Gerlach RF, Santos JET dos. Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism [Internet]. Critical Care Medicine. 2011 ; 39( 2): 349-356.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1097/ccm.0b013e3181fa3dfeVancouver
Neto-Neves EM, Dias-Júnior CA, Rizzi E, Castro MM de, Sônego F, Gerlach RF, Santos JET dos. Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism [Internet]. Critical Care Medicine. 2011 ; 39( 2): 349-356.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1097/ccm.0b013e3181fa3dfe
